The Science and Ethics of Antipsychotic Use in Children

In the past 10 years the number of antipsychotics prescribed to children with psychiatric disorders have skyrocketed. Despite this rapid growth, most medications have been inadequately studied in children for safety or efficacy and many have serious adverse health. Measures are needed to ensure that the health and safety of children are being protected, and debates have emerged over whether or not clinical trials in this population should be conducted. This edited volume reviews the latest findings for the safety and efficacy of antipsychotic use in children and examines tensions that are created by off-label use, both in clinical psychiatric practice and research. . Offers coverage of efficacy, prevalence, and adverse impacts of the use of antipsychotics in children. Explores ethics challenges of clinical research in this patient population. Serves as a platform for future discussions designed to increase the safety of children taking antispychotics. Edited work with chapters authored by leading neuroethicists in the field around the globe - the broadest, most expert coverage available INDICE: 1. Introduction 2. Prescribing Trends 3. Efficacy and Clinical Trials 4. Drug Safety 5. Alternative Treatment Options: The Case for Sleep 6. Non-pharmacological interventions for the treatment of mood, behaviour, and learning problems in young people 7. Ethics: Key Concepts and Big Issues 8. Implementing Change in Prescribing Practices 9. Canadian Initiatives

• ISBN: 978-0-12-800016-8
• Editorial: Academic Press
• Encuadernacion: Cartoné
• Páginas: 275
• Fecha Publicación: 12/06/2015
• Nº Volúmenes: 1
• Idioma: Inglés